COG5 inhibition induces glycosylation defects affecting chondrogenesis and interfering with Wnt, but not BMP signaling  by Cailotto, F. et al.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S142cartilage destruction in vitro. These effects are not mediated by the inhi-
bition of histone deacetylases or the induction of the Nrf2 transcription
factor but likely act via NFkB signalling. We are currently pursuing these
ﬁndings in vivo.
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HDAC1, 2 AND 7 AS MODULATORS OF PROTEOGLYCAN PRODUCTION:
THE EFFECTS OF SEPARATE AND SIMULTANEOUS KNOCKDOWN
R. Bakker 1, J.E. Bekkers 1, A.H. Kragten 1, D.B. Saris 1,2, W.J. Dhert 1,3,
L.B. Creemers 1, L.A. Vonk 1. 1UMC Utrecht, Utrecht, Netherlands; 2MIRA
Inst., Univ. of Twente, Enschede, Netherlands; 3Vet. Med., Univ. of Utrecht,
Utrecht, Netherlands
Purpose: Histone deacetylases (HDACs) regulate gene expression by
histone modiﬁcation. HDAC1, 2 and 7 expression is increased in OA
patients and they are associated with downregulation of several chon-
drogenic genes and increased matrix metalloproteinase-13 expression.
Therefore, this study investigated histone deacetylase knockdown as
a possible target to modulate cartilage metabolism.
Methods: OA chondrocytes were obtained from patients undergoing knee
arthroplasty. At passage 2, OA chondrocytes were transfected with siRNA
against HDAC1, 2, and 7 or a mock, or they were treated with the isotype-
selective HDAC inhibitor mocetinostat. Chondrocytes were reverse-trans-
fected during seeding at high density (1.26*106 cells per cm2) on collagen-
coated culture inserts in a 96-wells transwell system. Real-time PCR was
performed to examine gene expression levels of HDAC1, 2 and 7, aggrecan
(ACAN), type I collagen (COL1A1), type II collagen (COL2A1) and matrix
metallopeptidase 13 (MMP13). HDAC1, 2 and 7 were analyzed at the
protein level by Western blot. Glycosaminoglycan (GAG) and DNA content
were determined using a DMMB and Picogreen assay, respectively.
Results: Expression levels of the targeted HDAC were decreased by RNAi.
No differences were observed in GAG and DNA content between the
chondrocytes transfected with mock and HDAC1, 2 or 7-directed siRNA.
Transfection with HDAC1, 2 or 7 siRNA showed no effects on gene
expression levels of ACAN, COL1A1, COL2A1 and MMP13. Knockdown of
HDAC1 resulted in signiﬁcantly higher HDAC2 gene expression levels and
a trend towards higher HDAC7 gene expression levels. Knockdown of
HDAC2 increased HDAC1 and HDAC7 gene expression levels and knock-
down of HDAC7 resulted in increased HDAC1 and HDAC2 gene expression
levels. Transfection with HDAC1, 2, and 7 siRNA together, and treatment
with the isotype-selective HDAC inhibitor mocetinostat increased the
amount of GAG produced by the cells.
Conclusions: Speciﬁc knockdown of HDAC 1, 2 or 7 did not improve the
GAG production by OA chondrocytes, most likely due to the compensatory
upregulation of the other HDAC subtypes. Hence, HDAC 1, 2 and 7 seem to
have overlapping functions in modulating the GAG production of chon-
drocytes. Knockdown of HDAC1, 2 and 7 together did increase GAG
production. This suggests that modulation of multiple HDACs, is necessary
for gene-based treatment of OA.
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ACTIVATION OF NF-kB/P65 INITIATES CHONDROGENIC
DIFFERENTIATION OF CHONDROPROGENITOR CELLS
M.J. Caron 1, P.J. Emans 1, D.A. Surtel 1, A. Cremers 1, J.-W. Voncken 2,
T.J. Welting 1, L.W. van Rhijn 1. 1Dept. Orthopaedic Surgery, Maastricht
Univ. Med. Ctr., Maastricht, Netherlands; 2Dept. Molecular Genetics,
Maastricht Univ. Med. Ctr., Maastricht, Netherlands
Purpose: For the purpose of cartilage and bone regenerative techniques,
the initiation of chondrogenic differentiation from progenitor cells is an
important and precarious step that must be well-guided. NF-kB/p65 is
reported to be involved in regulation of chondrogenic differentiation.
However, whether it is involved in the initiation of chondrogenesis and its
relation to key chondrogenic transcription factor Sox9 and is poorly
understood. We hypothesized that the early onset of chondrogenic
differentiation is initiated by transient NF-kB/p65 signaling.
Methods: The role of NF-kB/p65 in early chondrogenesis was investigated
in different chondrogenic models: ATDC5 cells, hBMSCs, chicken periosteal
explants and mouse growth plates. NF-kB/p65 activation was manipulatedusing pharmacological inhibitors, RNAi and activating agents. Gene
expression and protein expression analyses, and (immuno)histochemical
stainings were employed to determine the role of NF-kB/p65 in early
chondrogenesis.
Results: All of the employed chondrogenic models showed that early
chondrogenic differentiation correlates with transient activation of NF-kB/
p65 and expression of its transcriptional targets (e.g. COX-2, TNFa, iNOS).
This early NF-kB/p65-mediated signaling leads to early transient expres-
sion of Sox9 and determines the subsequent chondrogenic outcome
(Col2a1 and Col10a1). Subtle stimulation of NF-kB/p65 activity resulted in
increased expression of cartilaginousmarkers in both our in vitro as well as
periosteal explant cultures, even in the absence of known chondrogenic
growth factors. In addition, early NF-kB/p65 activity and Sox9 expression
were enhanced by BMP-2, providing a possible explanation for BMP-2
driven chondrogenic differentiation.
Conclusions: The herein presented data demonstrate that NF-kB/p65
signaling, as well as its intensity and timing, represents one of the tran-
scriptional regulatory mechanisms of the chondrogenic developmental
program of chondroprogenitor cells. Importantly, this conceptmay be used
as a molecular tool to modulate chondrogenic differentiation and thereby
improve the success of cartilage regenerative techniques.
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COG5 INHIBITION INDUCES GLYCOSYLATION DEFECTS AFFECTING
CHONDROGENESIS AND INTERFERING WITH WNT, BUT NOT BMP
SIGNALING
F. Cailotto, F.P. Luyten, R.J. Lories. Katholieke Univ.it Leuven, Leuven, Belgium
Purpose: Osteoarthritis (OA) is a highly disabling pathology of the bone-
cartilage unit, to which both patient-dependent (weight excess, trauma.)
and genetic factors contribute. Recently, a locus on Chromosome 7 (7q22)
was linked to knee and hand OA by genome wide association study. In this
locus, the Conserved oligomeric Golgi complex subunit (COG) 5 gene
encodes a component of Golgi apparatus. Mutations in COG5 are associ-
ated with mild congenital glycosylation disorders, and COG5 expression is
higher in 3D than in monolayer cultures of articular chondrocytes. As
aspects of endochondral bone formation are recapitulated in OA (loss of
stable phenotype, hypertrophy), we investigated the role of COG5 in
chondrogenesis.
Methods: We used the ATDC5 chondrogenic cell line. Three independent
stable clonal colonies of each, control (empty vector) and COG5 knocked-
down cells (COG5-), were selected over 7 days (D) using puromycin. Clones
were cultured as high density micromasses (2x105 cells/10 ml) to mimic
the condensation step of developing cartilage in vivo. Chondrogenesis was
induced by culturing cells for 14 D in DMEM/F12 + 5% FBS, supplemented
with ITS [insulin (10 mg/ml), transferrin (10 mg/ml) and sodium selenite (30
nM)]. On D14, cells were switched to mineralization medium (aMEM + 5%
FBS, supplemented with ITS) to investigate the mineralization phase of
chondrogenesis. mRNA expression of typical chondrogenesis markers
(Aggrecan (Agg), type II (Col2a1) and X (Col10a1)) collagens were assessed
by quantitative RT-PCR. Likely, we assessed mRNA expression of Wnts (-4,
-5a, -5b, -11) and BMPs (-2, -4, -6, -7). Quantiﬁcation of Alcian Blue,
Safranin O, Sirius red and Alizarin red staining were used to evaluate
proteoglycans, collagens and mineralized content respectively. Western
blot was used to check the glycosylation status of Wnts, and the activation
status of Smad 1/5/8, typically increased in the proliferative phase of
chondrogenesis. Cell viability was checked with Live/Dead assay.
Results: During the early proliferation (D1-7) and late proliferation/
hypertrophy phase (D7-14), Col2a1 and Agg mRNA were strongly
increased, but to a lesser extent in COG5-. Safranin O and alcian blue
staining were also less upregulated in COG5-. Pro-chondrogenic BMP-4
increased, and was surprisingly signiﬁcantly higher in COG5-. This was
consistent with a higher activation of Smad 1/5/8 in COG5-.Wnt-4, -5a and
-5b mRNA increases were similar in control and COG5- cells. BMP-6 and
Col10a1 mRNA were increased at D14, but signiﬁcantly lower in COG5-.
A strongWnt-11mRNA increasewas observed at D7-14 in controls, but not
in COG5-. Moreover, analysis of Wnt-5a in culture supernatants revealed
a glycosylation defect in COG5-. Sirius red increased over time, and was
signiﬁcantly higher in controls. However, no differencewas detected in cell
viability. During mineralization phase (D14 to D21), BMP-2 and -7 mRNA
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a lesser extent in COG5-. Alizarin red was stronger in controls.
Conclusions: COG5 defect reduces the chondrogenesis process, despite
active BMP-Smad signaling. As COG5 also affected the expression and
glycosylation pattern of speciﬁcWnts, this underlines its critical role in the
fate of chondrogenic cells, and may point to a role in OA.
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SNORC, A NEW SPECIFIC MARKER OF HUMAN DIFFERENTIATED
ARTICULAR CHONDROCYTES
D. Ollitrault, Jr., F. Legendre, Jr., T. Gomez-Leduc, Jr., N. Bigot, Jr., S. Leclercq,
Sr., C. Bauge, Jr., K. Boumediene, Sr., M. Demoor, Sr., P. Galera, Sr., Lab. of
Cellular microenvironnement and pathologies (MILPAT), Caen, France
Purpose: Chondrocyte is the major cell type of cartilage and it synthesizes
an abundant extracellular matrix (ECM) that contains two main speciﬁc
markers, type II collagen and aggrecan. Other characteristic markers are
also expressed in cartilage, but their expression is less abundant than those
observed for type II collagen and aggrecan. These ECM components are
more present in the territorial or interterritorial matrix and, presently, no
speciﬁc marker of human cartilage have been identiﬁed on the membrane
of articular chondrocytes.
Methods: Snorc mRNA expression was studied by Q-RT-PCR in chon-
drocytes and during chondrogenesis induction in adult mesenchymal stem
cells (AMSCs) from bone marrow. The protein alignment of Snorc was
made with Geneious and the 3D modelisation was performed with the
iTASSER server from the Michigan University.
Results: In this study, we have analyzed a new speciﬁc marker of the
differentiated status of human articular chondrocytes (HACs). Snorc is
a small transmembrane proteoglycan (PG) composed of 121 amino acids.
We reported that its expression decreased when HACs are dediffer-
entiated by sub-culturing or upon IL-1b treatment. Conversely, Snorc
expression is increased during the redifferentiation of HACs by BMP-2 in
a 3D culture model in hypoxia. Furthermore, when chondrogenesis was
induced in human AMSCs, the expression of this PG is greatly enhanced,
as observed for type II collagen, aggrecan and SOX9. In addition, Snorc
seemed to be expressed in a tissue-speciﬁc manner because no expres-
sion was detected in the skin, bone and AMSCs. Finally, the transcription
activity of the SNORC gene could be regulated, indirectly or directly, by
several transcriptions factors involved in the transactivation of type II
collagen gene, such as Sp1, SOX9 and/or HIF-1a, whose each of them
present a putative DNA binding site in the SNORC proximal promoter. The
primary structure of Snorc and the modelization of its quaternary
structure in 3D were analyzed to compare this PG spatial organization
between Mouse and Human species. This approach reveals that Snorc
seems to conserve the same spatial organization and contains one or
probably two transmembrane domains, an extracellular and an intracel-
lular domain.
Conclusions: During the HACs dedifferentiation, Snorc mRNA levels are
decreased whereas they are increased during the redifferentiation of HACs
or during the induction of chondrogenesis in AMSCs from bone marrow.
Thus, these results allow us to consider Snorc as a new speciﬁc marker of
the human articular cartilage that should be evaluated in order to better
appreciate the differentiation status of chondrocytes. Moreover, Snorc
could play an important role in cartilage homeostasis by potentially
inducing an intracellular signalisation pathway or perhaps participating to
the territorial matrix anchoring.
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GLUCOSAMINE AND AN ITS PEPTIDYL-DERIVATIVE INFLUENCE
TNF-ALPHA ACTIVATION OF NF-kB PATHWAY
L. Politi, D. Stoppoloni, R. Scandurra, A. Scotto d'Abusco. Univ. of Roma,
Roma, Italy
Purpose: NF-kB transcription factor regulates several cell signaling path-
ways, such as differentiation and inﬂammation, which are both altered in
osteoarthritis. IKKa and IKKb are kinases involved in the activation of the
NF-kB transcription factor. The aim of the present study was to determine
the effects of glucosamine (GlcN), which is administered in the treatmentof osteoarthritis, and of its 2-(N-Acetyl)-L-phenylalanylamido-2-deoxy-b-
D-glucose (NAPA) derivative, synthesized in our laboratory, on IKK kinases
and, consequently, on NF-kB activation in human chondrocytes.
Methods: The human chondrosarcoma cell line HTB-94 and human
primary chondrocytes were stimulated with TNFa after pre-treatment
with GlcN or NAPA. Gene mRNA expression level was evaluated by Real
Time-PCR. IkBa phosphorylation and p65 nuclear re-localization were
analyzed by Western blotting, IKKa nuclear translocalization was also
investigated by immunocytochemistry and Western blotting. IKK kinase
activity was studied by in vitro kinase assay.
Results: After TNFa stimulation, the mRNA expression level of some of the
genes under NF-kB control, such as IL-6 and IL-8, increased, while treat-
ment with GlcN and NAPA reverted the effect. We investigated the
possibility that GlcN and NAPA inhibit IKK kinase activity and found that
NAPA inhibits the IKKa kinase activity, whereas GlcN does not. Interest-
ingly, both GlcN and NAPA inhibit IKKa nuclear re-localization.
Conclusions: Our results demonstrate that glucosamine and its peptidyl-
derivative can interfere with NF-kB signaling pathway by inhibiting IKKa
activity in human chondrocytes. However, the mechanism of action of the
two molecules is not completely overlapping. While NAPA can both
speciﬁcally inhibit the IKKa kinase activity and IKKa nuclear trans-
localization, GlcN only acts on IKKa nuclear translocalization.
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INDUCTION OF HIGH TEMPERATURE REQUIREMENT A1, A SERINE
PROTEASE, BY TGF-BETA1 IN KNEE JOINTS OF MOUSE MODELS OF OA
Y. Li 1, I. Golshirazian 2, B.J. Asbury 2, J. Kim 2, L. Xu 1. 1Harvard Med. Sch.,
Boston, MA, USA; 2Harvard Sch. of Dental Med., Boston, MA, USA
Purpose: High temperature requirement A 1 (HTRA1), a serine protease,
has been implicated as a possible factor in the pathogenesis of osteoar-
thritis (OA) and rheumatoid arthritis (RA). In this study we examined the
effects of high temperature, tumor necrosis factors alpha (TNFa), trans-
forming growth factor beta 1 (TGF-b1), and a high hydrostatic pressure on
the induction of HTRA1 in chondrocytes.
Methods: Cell culture- Human primary chondrocytes were grown in the
medium supplemented with 10% FBS. Cells were then divided into
a control group or one of four experimental conditions: heating to 42oC,
addition of recombinant human TNFa (10ng/ml), addition of recombinant
human TGF-b1 (10ng/ml), or high hydrostatic pressure (5,000 psi ¼
34 MPa). Cells were then lysed with subsequent RNA extraction. Ex vivo
articular cartilage culture of mouse hip- Hip articular cartilage from six 10-
week old C57BL mice were pooled and homogenized with PT-DA 2112/EC
polytron at the lowest speed for 30 seconds. The sample was ﬁltered
through a 100 mmNylon Cell Strainer. The ﬁltered sample was re-dissolved
in 1ml of DMEM and divided into twowells. The samplewas cultured with
or without TGF-b1 (10ng/ml) for 6, 12 and 24 hrs at 37 oC. The cartilages
were then collected for isolation of total RNAs. Real-time PCR- cDNAs were
synthesized with total RNAs from the cultured human chondrocytes and
mouse hip cartilages. The level of HTRA1 in the samples was examined. A
cDNA sample in each experiment was tested in triplicate and each
experiment was performed twice. Immunohistology- The expression of
TGF-b1, p-Smad1 and p-Smad2 in Col11a1+/- mice at the age of 10 weeks
(a genetic form of mouse model of OA) and mice with surgical destabili-
zation of the medial meniscus (DMM, a non-genetic form of model of OA)
were examined (n¼4 in each experimental group). Parafﬁn sections were
incubated with polyclonal antibodies against TGF-b1, p-Smad1, and p-
Smad2. After overnight incubation at 4C, the sections were treated with
a biotinylated secondary antibody and peroxidase substrate. Staining with
isotype-matched normal IgG and staining without primary antibody were
also performed as negative controls. Intra-articular injection of a neutral-
izing TGF-b1 antibody into mice knee joints- The neutralizing TGF-b1
antibody (25 mg) or PBS as control was injected into the cavity of knee
joints of Col11a1+/- mice at the age of 10 weeks. An additional injection
was performed 2 weeks later. Knee joints were collected 2 weeks after the
second injection. Expression proﬁles of p-Smad2 and HtrA1 were exam-
ined by double immunohistostaining. Double immunohistostaining-
Sections from Col11a1+/- mice treated with the neutralizing TGF-b1
antibody, and DMM mice were incubated with primary polyclonal anti-
bodies against p-Smad2 and HtrA1 at 4C overnight. The sections were
